SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-20-254551
Filing Date
2020-09-25
Accepted
2020-09-25 16:03:05
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B4 d922470d424b4.htm 424B4 2092587
2 GRAPHIC g922470g07c87.jpg GRAPHIC 196773
3 GRAPHIC g922470g09b58.jpg GRAPHIC 72134
4 GRAPHIC g922470g09c62.jpg GRAPHIC 44550
5 GRAPHIC g922470g11d74.jpg GRAPHIC 64310
6 GRAPHIC g922470g14v50.jpg GRAPHIC 50578
7 GRAPHIC g922470g19s60.jpg GRAPHIC 49788
8 GRAPHIC g922470g23m05.jpg GRAPHIC 78515
9 GRAPHIC g922470g33u33.jpg GRAPHIC 49962
10 GRAPHIC g922470g34k00.jpg GRAPHIC 150976
11 GRAPHIC g922470g35o52.jpg GRAPHIC 112102
12 GRAPHIC g922470g47b01.jpg GRAPHIC 109126
13 GRAPHIC g922470g56d20.jpg GRAPHIC 120443
14 GRAPHIC g922470g77u33.jpg GRAPHIC 73790
  Complete submission text file 0001193125-20-254551.txt   3703260
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-248627 | Film No.: 201200144
SIC: 2834 Pharmaceutical Preparations